BNB Treasury Company Applied DNA Completes PIPE Financing, Acquires an Additional 4,908 BNB

BlockBeats News, October 22, Applied DNA Sciences, Inc. (NASDAQ: BNBX), a biotechnology company focused on advancing a revenue-generating BNB digital asset treasury strategy and commercializing nucleic acid production solutions, today announced the successful completion of the previously announced Public Investment in Private Equity (PIPE) financing, led by institutional DeFi and TradFi investors.

This PIPE financing round brought approximately $27 million in total proceeds to the company (net of underwriting and related expenses), with the potential for an additional $31 million in total proceeds through the exercise of warrants. The total proceeds from this PIPE round include:

$15.3 million in cash and stablecoins;

and $11.71 million in OBNB Trust Units (units of OBNB trust).

The company received 0.126 OBNB Trust Units per prefunded warrant and common warrant, totaling 435,638 trust units, representing an indirect ownership interest in 10,647 BNB tokens.

In addition, the company also announced today that it has purchased an additional 4,908 BNB tokens, with a total value of approximately $5.3 million as of 10:00 PM Eastern Time on October 20, 2025.